search
Back to results

Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure.

Primary Purpose

Corona Virus Infection, Hypoxic Respiratory Failure

Status
Not yet recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Awake timed prone and repositioning
Sponsored by
Second Affiliated Hospital, School of Medicine, Zhejiang University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Corona Virus Infection focused on measuring Awake prone positioning

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adults ≥ 18 years of age Awake patients without endotracheal intubation Suspected or confirmed infection of COVID-19 Hypoxemia requiring oxygen supplementation ≥ 0.4 FiO2 or ≥ 5L/min via nasal cannula Bilateral or unilateral chest infiltrates on x-ray or HRCT Admitted to the ICU or an acute care unit where hemodynamic and respiratory Willingness to comply with the protocol and provide written informed consent Exclusion Criteria: Risk of airway obstruction or even asphyxia Need for emergent intubation after admission Respiratory failure caused by cardiogenic pulmonary edema Unable to implement timed prone and repositioning due to any cause Injury or wound on the ventral body surface affecting the prone position Unstable fracture of cervical vertebra and spine Glaucoma or other sharp increases in intraocular pressure Intracranial hypertension caused by traumatic brain injury etc. Significantly high risk of pulmonary embolism Acute hemorrhagic disease Respiratory rate >40 breaths/min, with significant dyspnea Transcutaneous oxygen saturation can not be continuously monitored Hemodynamic instability requiring vasoactive drugs (systolic blood pressure <90 mmHg or mean arterial pressure <65 mmHg despite adequate volume resuscitation) Awareness disorder or inability to accept instructions, communication barrier with the nursing team, inability to use language or pager to call for help Difficulty or limitation in autonomous movement, inability to adjust the position without assistance from others Body mass index > 37 kg/m2

Sites / Locations

  • Changxing People's Hospital
  • The Second Affiliated Hospital Zhejiang University School of Medicine
  • Lishui Municipal Central Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Awake timed prone and repositioning group

Standard care group

Arm Description

Patients' cumulative prone and repositioning time is encouraged to reach 8-10 hours per day for 4 days following a timed prone and repositioning strategy.

Patients can change their positions freely according to their own needs. Health providers do not take the initiative to give guidance on prone and repositioning.

Outcomes

Primary Outcome Measures

Endotracheal Intubation rate
The incidence of endotracheal Intubation within 30 days of study enrollment

Secondary Outcome Measures

Mortality
All-cause death within 30 days of study enrollment
Days of non-invasive ventilation
Number of days alive and free of mechanical ventilation within 30 days of study enrollment
Days alive and outside the ICU
Number of days alive and outside the ICU within 30 days of study enrollment
Clinical events
Clinical events include time to treatment failure( treatment failure defined as intubation or death); time to intubation; time to death; duration of invasive mechanical ventilation in intubated patients surviving to day 30; mortality in invasively mechanically ventilated patients; and physiological response to awake prone positioning, including the ratio of SpO2:FiO2 to respiratory rate, known as the ROX index.

Full Information

First Posted
January 14, 2023
Last Updated
January 14, 2023
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
search

1. Study Identification

Unique Protocol Identification Number
NCT05689216
Brief Title
Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure.
Official Title
Efficacy of Timed Awake Prone and Repositioning in Patients With Covid-19-induced Hypoxic Respiratory Failure: a Multi-center, Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 18, 2023 (Anticipated)
Primary Completion Date
February 18, 2024 (Anticipated)
Study Completion Date
February 18, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Awake prone positioning has been reported to improve oxygenation for patients with COVID-19. Awake timed and repositioning is a novel method to improve patients' compliance and prolong the prone time. This study aims to explore the impact of timed prone and repositioning on the intubation rate and prognosis of COVID-19 patients with hypoxic respiratory failure.
Detailed Description
Patients with COVID-19 may develop severe illness characterized by progressive hypoxic respiratory failure, resulting in the need for invasive mechanical ventilation. Reducing the rate of endotracheal intubation in patients with hypoxic respiratory failure can be beneficial to the prognosis, economize iatrical resources and reduce sanitary investment. Some studies have shown that prone positioning can improve oxygenation to some extent in patients receiving invasive mechanical ventilation due to severe ARDS. Whether awake prone positioning can reduce endotracheal intubation and mortality in COVID-19 patients with hypoxic respiratory failure is still controversial. A meta-analysis found that the awake prone positioning was safe and feasible to reduce the risk of intubation or death. However, the multicenter randomized controlled trial (RCT) conducted by Alhazzani et al pointed out that the awake prone positioning group did not significantly reduce the rate of endotracheal intubation when compared with the standard of care. Some researchers thought the time of prone positioning is an important factor for the different results. In previous studies, the median duration of prone positioning was only 4.8-5 hours per day but some guidelines recommend the duration should be more than 8 hours. Therefore, increasing patient adherence in the awake prone positioning and extending prone positioning time are of great importance. Awake timed prone and repositioning is a novel method proposed in recent years, which can improve patients' compliance and prolong the time of treatment. This study intends to ask whether awake timed prone and repositioning could impact the intubation rate and prognosis of unincubated patients with hypoxic respiratory failure induced by COVID-19.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Corona Virus Infection, Hypoxic Respiratory Failure
Keywords
Awake prone positioning

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
286 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Awake timed prone and repositioning group
Arm Type
Experimental
Arm Description
Patients' cumulative prone and repositioning time is encouraged to reach 8-10 hours per day for 4 days following a timed prone and repositioning strategy.
Arm Title
Standard care group
Arm Type
No Intervention
Arm Description
Patients can change their positions freely according to their own needs. Health providers do not take the initiative to give guidance on prone and repositioning.
Intervention Type
Behavioral
Intervention Name(s)
Awake timed prone and repositioning
Intervention Description
Patients were instructed to adopt a timed prone and repositioning strategy with 4 sessions for four consecutive days. Session 1, lying on the belly; Session 2, lying on the right side; Session 3, sitting up; Session 4, lying on the left side; then back to session 1 (30 minutes to two hours for each session). The daily duration of timed prone and repositioning is strongly recommended for 8-10 hours.
Primary Outcome Measure Information:
Title
Endotracheal Intubation rate
Description
The incidence of endotracheal Intubation within 30 days of study enrollment
Time Frame
Day 30
Secondary Outcome Measure Information:
Title
Mortality
Description
All-cause death within 30 days of study enrollment
Time Frame
Day 30
Title
Days of non-invasive ventilation
Description
Number of days alive and free of mechanical ventilation within 30 days of study enrollment
Time Frame
Day 30
Title
Days alive and outside the ICU
Description
Number of days alive and outside the ICU within 30 days of study enrollment
Time Frame
Day 30
Title
Clinical events
Description
Clinical events include time to treatment failure( treatment failure defined as intubation or death); time to intubation; time to death; duration of invasive mechanical ventilation in intubated patients surviving to day 30; mortality in invasively mechanically ventilated patients; and physiological response to awake prone positioning, including the ratio of SpO2:FiO2 to respiratory rate, known as the ROX index.
Time Frame
Day 30

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults ≥ 18 years of age Awake patients without endotracheal intubation Suspected or confirmed infection of COVID-19 Hypoxemia requiring oxygen supplementation ≥ 0.4 FiO2 or ≥ 5L/min via nasal cannula Bilateral or unilateral chest infiltrates on x-ray or HRCT Admitted to the ICU or an acute care unit where hemodynamic and respiratory Willingness to comply with the protocol and provide written informed consent Exclusion Criteria: Risk of airway obstruction or even asphyxia Need for emergent intubation after admission Respiratory failure caused by cardiogenic pulmonary edema Unable to implement timed prone and repositioning due to any cause Injury or wound on the ventral body surface affecting the prone position Unstable fracture of cervical vertebra and spine Glaucoma or other sharp increases in intraocular pressure Intracranial hypertension caused by traumatic brain injury etc. Significantly high risk of pulmonary embolism Acute hemorrhagic disease Respiratory rate >40 breaths/min, with significant dyspnea Transcutaneous oxygen saturation can not be continuously monitored Hemodynamic instability requiring vasoactive drugs (systolic blood pressure <90 mmHg or mean arterial pressure <65 mmHg despite adequate volume resuscitation) Awareness disorder or inability to accept instructions, communication barrier with the nursing team, inability to use language or pager to call for help Difficulty or limitation in autonomous movement, inability to adjust the position without assistance from others Body mass index > 37 kg/m2
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yuanyuan Yao, M.D.
Phone
+86-18058783258
Email
yuanyuan58@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Min Yan, M.D.
Organizational Affiliation
Second Affiliated Hospital, School of Medicine, Zhejiang University
Official's Role
Study Chair
Facility Information:
Facility Name
Changxing People's Hospital
City
Changxing
State/Province
Zhejiang
ZIP/Postal Code
313199
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
jingfen Jin
Phone
+86-13757118239
Facility Name
The Second Affiliated Hospital Zhejiang University School of Medicine
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310000
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Min Yan, Doctor
Email
zryanmin@zju.edu.cn
Facility Name
Lishui Municipal Central Hospital
City
Lishui
State/Province
Zhejiang
ZIP/Postal Code
323020
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meifen Chen, Doctor
Phone
+86-13567618608

12. IPD Sharing Statement

Citations:
PubMed Identifier
35321918
Citation
Fralick M, Colacci M, Munshi L, Venus K, Fidler L, Hussein H, Britto K, Fowler R, da Costa BR, Dhalla I, Dunbar-Yaffe R, Branfield Day L, MacMillan TE, Zipursky J, Carpenter T, Tang T, Cooke A, Hensel R, Bregger M, Gordon A, Worndl E, Go S, Mandelzweig K, Castellucci LA, Tamming D, Razak F, Verma AA; COVID Prone Study Investigators. Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE). BMJ. 2022 Mar 23;376:e068585. doi: 10.1136/bmj-2021-068585.
Results Reference
background
PubMed Identifier
32189136
Citation
Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020 Mar 18;10(1):33. doi: 10.1186/s13613-020-00650-2. No abstract available.
Results Reference
background
PubMed Identifier
21199551
Citation
Wright AD, Flynn M. Using the prone position for ventilated patients with respiratory failure: a review. Nurs Crit Care. 2011 Jan-Feb;16(1):19-27. doi: 10.1111/j.1478-5153.2010.00425.x.
Results Reference
background
PubMed Identifier
12092293
Citation
Murray TA, Patterson LA. Prone positioning of trauma patients with acute respiratory distress syndrome and open abdominal incisions. Crit Care Nurse. 2002 Jun;22(3):52-6. No abstract available.
Results Reference
background
PubMed Identifier
33823862
Citation
Langer T, Brioni M, Guzzardella A, Carlesso E, Cabrini L, Castelli G, Dalla Corte F, De Robertis E, Favarato M, Forastieri A, Forlini C, Girardis M, Grieco DL, Mirabella L, Noseda V, Previtali P, Protti A, Rona R, Tardini F, Tonetti T, Zannoni F, Antonelli M, Foti G, Ranieri M, Pesenti A, Fumagalli R, Grasselli G; PRONA-COVID Group. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. 2021 Apr 6;25(1):128. doi: 10.1186/s13054-021-03552-2.
Results Reference
background
PubMed Identifier
35799288
Citation
Tasaka S, Ohshimo S, Takeuchi M, Yasuda H, Ichikado K, Tsushima K, Egi M, Hashimoto S, Shime N, Saito O, Matsumoto S, Nango E, Okada Y, Hayashi K, Sakuraya M, Nakajima M, Okamori S, Miura S, Fukuda T, Ishihara T, Kamo T, Yatabe T, Norisue Y, Aoki Y, Iizuka Y, Kondo Y, Narita C, Kawakami D, Okano H, Takeshita J, Anan K, Okazaki SR, Taito S, Hayashi T, Mayumi T, Terayama T, Kubota Y, Abe Y, Iwasaki Y, Kishihara Y, Kataoka J, Nishimura T, Yonekura H, Ando K, Yoshida T, Masuyama T, Sanui M; ARDS Clinical Practice Guideline 2021 committee from the Japanese Society of Intensive Care Medicine, the Japanese Respiratory Society, and the Japanese Society of Respiratory Care Medicine. ARDS Clinical Practice Guideline 2021. J Intensive Care. 2022 Jul 8;10(1):32. doi: 10.1186/s40560-022-00615-6.
Results Reference
background
PubMed Identifier
33534774
Citation
Serpa Neto A, Checkley W, Sivakorn C, Hashmi M, Papali A, Schultz MJ; COVID-LMIC Task Force and the Mahidol-Oxford Research Unit (MORU). Pragmatic Recommendations for the Management of Acute Respiratory Failure and Mechanical Ventilation in Patients with COVID-19 in Low- and Middle-Income Countries. Am J Trop Med Hyg. 2021 Jan 13;104(3_Suppl):60-71. doi: 10.4269/ajtmh.20-0796.
Results Reference
background
PubMed Identifier
34425070
Citation
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.
Results Reference
background
PubMed Identifier
35569448
Citation
Alhazzani W, Parhar KKS, Weatherald J, Al Duhailib Z, Alshahrani M, Al-Fares A, Buabbas S, Cherian SV, Munshi L, Fan E, Al-Hameed F, Chalabi J, Rahmatullah AA, Duan E, Tsang JLY, Lewis K, Lauzier F, Centofanti J, Rochwerg B, Culgin S, Nelson K, Abdukahil SA, Fiest KM, Stelfox HT, Tlayjeh H, Meade MO, Perri D, Solverson K, Niven DJ, Lim R, Moller MH, Belley-Cote E, Thabane L, Tamim H, Cook DJ, Arabi YM; COVI-PRONE Trial Investigators and the Saudi Critical Care Trials Group. Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial. JAMA. 2022 Jun 7;327(21):2104-2113. doi: 10.1001/jama.2022.7993.
Results Reference
background
PubMed Identifier
35305308
Citation
Li J, Luo J, Pavlov I, Perez Y, Tan W, Roca O, Tavernier E, Kharat A, McNicholas B, Ibarra-Estrada M, Vines DL, Bosch NA, Rampon G, Simpson SQ, Walkey AJ, Fralick M, Verma A, Razak F, Harris T, Laffey JG, Guerin C, Ehrmann S; Awake Prone Positioning Meta-Analysis Group. Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis. Lancet Respir Med. 2022 Jun;10(6):573-583. doi: 10.1016/S2213-2600(22)00043-1. Epub 2022 Mar 16.
Results Reference
background
Links:
URL
https://ics.ac.uk/resource/guidance-for-conscious-proning.html
Description
https://emcrit.org/wp-content/uploads/2020/04/2020-04-12-Guidance-for-conscious-proning.pdf

Learn more about this trial

Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure.

We'll reach out to this number within 24 hrs